about
Patterns of Glaucoma Medication Adherence over Four Years of Follow-UpMedical Management of Glaucoma in the 21st Century from a Canadian PerspectiveBlindness and Glaucoma: A Multicenter Data Review from 7 Academic Eye ClinicsLatanoprost versus timolol as first choice therapy in patients with ocular hypertension. A cost-effectiveness analysis.Long-term trends in glaucoma-related blindness in Olmsted County, Minnesota.Prevalence of self-reported early glaucoma eye drop bottle exhaustion and associated risk factors: a patient surveyDeveloping the clinical components of a complex intervention for a glaucoma screening trial: a mixed methods study.Portsmouth visual field database: an audit of glaucoma progressionCost-effectiveness of medications compared with laser trabeculoplasty in patients with newly diagnosed open-angle glaucoma.Access to eye health services among indigenous Australians: an area level analysis.Glaucoma diagnostics.Why Do People (Still) Go Blind from Glaucoma?Imaging in glaucoma.Is it worthwhile to conduct a randomized controlled trial of glaucoma screening in the United Kingdom?Impact of Socioeconomic Status on the Diagnosis of Primary Open-Angle Glaucoma and Primary Angle Closure Glaucoma: A Nationwide Population-Based Study in Taiwan.New paradigms in the mechanisms and management of glaucoma.The effect of appointment rescheduling on monitoring interval and patient attendance in the glaucoma outpatient clinic.Ten-year outcomes in newly diagnosed glaucoma patients: mortality and visual functionGlaucoma in developing countries.Exploring the influence of patient-provider communication on intraocular pressure in glaucoma patients.Glaucoma Blindness at a Tertiary Eye Care Center.Cost-effectiveness of latanoprost and timolol maleate for the treatment of glaucoma in Scandinavia and the United Kingdom, using a decision-analytic health economic model.Practical recommendations for measuring rates of visual field change in glaucoma.Risk factors for progression to blindness in high tension primary open angle glaucoma: Comparison of blind and nonblind subjects.Prospective Observational Post-marketing Study of Tafluprost 0.0015%/Timolol 0.5% Combination Ophthalmic Solution for Glaucoma and Ocular Hypertension: Short-Term Efficacy and Safety.Examining Delay Intervals in the Diagnosis and Treatment of Primary Open Angle Glaucoma in an Egyptian Population and Its Impact on Lifestyle.The evidence base to select a method for assessing glaucomatous visual field progression.Factors associated with lifetime risk of open-angle glaucoma blindness.The risk of newly developed visual impairment in treated normal-tension glaucoma: 10-year follow-up.The effect of additional topical cyclosporine or vitamin A on the ocular surface during antiglaucoma medication administration.Effects of antiglaucoma drugs on the ocular surface in rabbits: a fixed-combination drug versus two concomitant drugs.Cases of advanced visual field loss at referral to glaucoma clinics - more men than women?Change in visual acuity and associated risk factors after trabeculectomy with adjunctive mitomycin C.Cost-effectiveness of early detection and treatment of ocular hypertension and primary open-angle glaucoma by the ophthalmologist.Primary angle closure glaucoma: a developing world perspective.The rising cost of glaucoma drugs.ReGAE 2: glaucoma awareness and the primary eye-care service: some perceptions among African Caribbeans in Birmingham UK.ReGAE 1: using the Shah-Cross model as an orientating framework in African-Caribbean glaucoma research.Lifetime visual prognosis of patients with glaucoma.Glaucoma blind registration in Fife (2000-2009) - a retrospective cohort study.
P2860
Q27304671-D13D68FB-48D2-4110-88F5-F725AA008CB6Q28074316-E09F62E9-CF58-4D6D-82C7-72EA5EF5A02EQ30000044-129C39D3-61CB-4577-B78F-495E33C6C61FQ33669278-EE3AB6DC-661F-4273-81B7-413A99467CCDQ33685328-F899DE85-17D4-4D00-89B3-4518DCD28216Q33812135-2CAB4B16-C238-4849-8BB3-B6EA015C0CE3Q33878922-1766F354-959B-42AD-BBF5-78B74A3449F6Q34055002-3269273F-870A-4B1D-9694-A3C4CB4BAF31Q34158299-6BB29E0C-22C3-4C6C-8F0B-8ED803E18ABBQ34418820-6F1977AD-C846-4638-8514-9F6D3928BD46Q34577535-C0AA2B69-5DF0-4AAC-97CA-BB713A2298A7Q35160642-9A0190E0-CA9C-445D-A94A-21613D5C8B31Q35753308-52E62173-E5F8-4E56-AFB7-85C5B174082FQ35875638-2188C743-D230-44BF-93A1-53D59E2B1E29Q35932136-DF3E2387-F3E0-42D4-95B1-4880D9E462B1Q35949074-1B04C3D9-C8E9-47AB-A529-BB966F27C03EQ35955582-3B330DC6-FAE0-497B-ABFD-BCE72CA7C023Q36025849-158565E6-2868-4AB6-99E6-F44C8ECCA259Q36377710-E5F8A990-586B-4F3A-AB2C-1EF0D6379472Q36437242-E2F77CB8-1882-4937-A098-BD45BD279DC6Q36687683-E6040735-0238-48F0-B993-837A2B2A43CBQ36920000-2C9CC9B3-1B04-4321-A1EA-676C2D78FC0FQ37062593-F8BE766E-8186-4300-ABD5-6240398E6ACFQ37236084-7A5FDD3D-C8FB-4532-AE3E-B04F55A33FD0Q37444732-6B716575-E892-4002-8285-AB0043627E39Q37571767-23E6F4F9-FC93-4769-8589-EF1921BAB8B9Q37910990-B936BCDE-4147-4209-893B-41C609424EE6Q38120316-F4E11F17-0466-4ED4-A9C1-6917FEE3D3E2Q38201842-0DB1FC0A-0A41-49D6-B7F4-00802F21BB54Q38462657-D396B304-D56A-418B-81E1-913E007CA11EQ38470550-7013A2CB-6C04-4C8A-8904-BB1AB838E75FQ39175337-7E32E3BE-A6EF-430D-A39B-73B8468CC398Q39785643-EDDF5DDB-CA3B-4D0B-8593-C027FA05A05CQ42604604-A76E82B1-1E0C-4A04-9071-12E5A24BBF08Q42622397-CF97D3BA-263B-4388-AD2D-57B69EB42774Q42835925-559CA748-3AFE-4583-8BF9-02430B1AD46CQ43938441-6A0EFD89-0935-4D38-A81B-908FCCD300E3Q44659081-35A5E976-3E07-4E15-A08B-12739F1DC97BQ46145606-A56E1A30-E370-4A00-A077-E37CBA7E7A06Q50433791-C48BF937-E7CB-4E13-B821-DED903C251D1
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Blindness in patients with treated open-angle glaucoma.
@ast
Blindness in patients with treated open-angle glaucoma.
@en
type
label
Blindness in patients with treated open-angle glaucoma.
@ast
Blindness in patients with treated open-angle glaucoma.
@en
prefLabel
Blindness in patients with treated open-angle glaucoma.
@ast
Blindness in patients with treated open-angle glaucoma.
@en
P1433
P1476
Blindness in patients with treated open-angle glaucoma.
@en
P2093
Philip P Chen
P304
P356
10.1016/S0161-6420(02)01974-7
P577
2003-04-01T00:00:00Z